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The glycan profile of therapeutic monoclonal antibodies frequently plays an important role in their biological
function and pharmacokinetics. Therefore, improved control of the glycosylation profile of biopharmaceutical
monoclonal antibodies has become an increased priority during late stage and commercial manufacturing of
New Biological Entities as well as biosimilars. Two ways to obtain better control are through process parameter
optimization and/or through addition of media supplements to the production reactor. Cell culture
supplementation with mycophenolic acid is one method to efficiently manipulate N-glycan profiles of monoclonal
antibodies, notably the level of fucosylation. We have observed at least for some CHO-based cell culture
processes, that the timing of mycophenolic acid addition to the cell culture process relative to the cell growth
profile is important to fine-tune the effect on the glycoprofile. This poster presents a case study where batch-tobatch variation of the N-glycan content of fucose for a monoclonal antibody at harvest could be correlated to the
mycophenolic acid dose timing relative to the viable cell volume profile measured online by use of capacitance
probes in 15 kL large-scale manufacturing bioreactors. Scale-down runs performed at 3 L scale with different
timing of mycophenolic acid addition supported these observations. These data demonstrates how online
capacitance probe measurements potentially could be used to optimize the process parameter mycophenolic
acid dose timing, and thereby, further improve control of product N-glycan profile for this process.

